ROXANNA BARZEGAR-DARVISH: Open Payments
NPI 1174291918 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 69 payments from 18 companies in 2025. Trend: 2023 $465 · 2024 $900 · 2025 $1,532
Food & beverage: $1,532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $605 |
| Axsome Therapeutics, Inc. | 9 | $173 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Noven Therapeutics, LLC | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Bausch Health US, LLC | 2 | $43 |
Products named: BOTOX, VRAYLAR, Xelstrym, Sunosi, TRINTELLIX, Auvelity, INGREZZA, Jornay PM.
Industry payments across GA — which companies pay providers there.
